Abuse-deterrent opioids: an update on current approaches and considerations
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Abuse-deterrent opioids: an update on current approaches and considerations
Authors
Keywords
-
Journal
CURRENT MEDICAL RESEARCH AND OPINION
Volume 34, Issue 4, Pages 711-723
Publisher
Informa UK Limited
Online
2017-12-21
DOI
10.1080/03007995.2017.1419171
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Marshaling FDA Benefit-Risk Expertise to Address the Current Opioid Abuse Epidemic
- (2017) Scott Gottlieb et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Secular trends in opioid prescribing in the USA
- (2017) Edmund Pezalla et al. Journal of Pain Research
- Vital Signs: Changes in Opioid Prescribing in the United States, 2006–2015
- (2017) Gery P. Guy et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting
- (2016) PM Coplan et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Decreased diversion by doctor-shopping for a reformulated extended release oxycodone product (OxyContin)
- (2016) Howard D. Chilcoat et al. DRUG AND ALCOHOL DEPENDENCE
- Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone
- (2016) Stevan Geoffrey Severtson et al. DRUG AND ALCOHOL DEPENDENCE
- Oral Human Abuse Potential of Oxycodone DETERx®(Xtampza®ER)
- (2016) Ernest A. Kopecky et al. JOURNAL OF CLINICAL PHARMACOLOGY
- (263) A model to quantify potential medical events avoided and cost savings from abuse deterrent opioids
- (2016) A. White et al. JOURNAL OF PAIN
- Relationship between Nonmedical Prescription-Opioid Use and Heroin Use
- (2016) Wilson M. Compton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abuse Potential with Oral Route of Administration of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users
- (2016) Mona Darwish et al. PAIN MEDICINE
- Intravenous abuse potential study of oxycodone alone or in combination with naltrexone in nondependent recreational opioid users
- (2016) Miroslav Backonja et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- Evaluation of Abuse-Deterrent or Tamper-Resistant Opioid Formulations on Overall Health Care Expenditures in a State Medicaid Program
- (2016) Shellie L. Keast et al. Journal of Managed Care & Specialty Pharmacy
- Abuse and Diversion of Immediate Release Opioid Analgesics as Compared to Extended Release Formulations in the United States
- (2016) Janetta L. Iwanicki et al. PLoS One
- Assessing the Subjective and Physiological Effects of Intranasally Administered Crushed Extended-Release Morphine Formulations with and without a Sequestered Naltrexone Core in Recreational Opioid Users
- (2016) Beatrice Setnik et al. Pain Research & Management
- The introduction of a potentially abuse deterrent oxycodone formulation: Early findings from the Australian National Opioid Medications Abuse Deterrence (NOMAD) study
- (2015) Louisa Degenhardt et al. DRUG AND ALCOHOL DEPENDENCE
- Intranasal administration of crushed ALO-02 (extended-release oxycodone with sequestered naltrexone): A randomized, controlled abuse-potential study in nondependent recreational opioid users
- (2015) Beatrice Setnik et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Trends in Opioid Analgesic Abuse and Mortality in the United States
- (2015) Richard C. Dart et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended-Release Oxycodone Formulations with Abuse-Deterrent Properties
- (2015) Jeff Gudin et al. PAIN MEDICINE
- Rates of Opioid Dispensing and Overdose After Introduction of Abuse-Deterrent Extended-Release Oxycodone and Withdrawal of Propoxyphene
- (2015) Marc R. Larochelle et al. JAMA Internal Medicine
- Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States
- (2015) Theodore J. Cicero et al. JAMA Psychiatry
- Use of prescription opioids with abuse-deterrent technology to address opioid abuse
- (2014) Edward Michna et al. CURRENT MEDICAL RESEARCH AND OPINION
- Societal Economic Benefits Associated with an Extended-Release Opioid with Abuse-Deterrent Technology in the United States
- (2014) Noam Y. Kirson et al. PAIN MEDICINE
- Development and validation of algorithms to identify acute diverticulitis
- (2014) Aniket Kawatkar et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Reductions in reported deaths following the introduction of extended-release oxycodone (OxyContin) with an abuse-deterrent formulation
- (2014) Nelson E. Sessler et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Medical cost savings associated with an extended-release opioid with abuse-deterrent technology in the US
- (2014) Louis F. Rossiter et al. JOURNAL OF MEDICAL ECONOMICS
- Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse-deterrent controlled-release tablets in recreational opioid users
- (2013) Stephen C. Harris et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Reduced Abuse, Therapeutic Errors, and Diversion Following Reformulation of Extended-Release Oxycodone in 2010
- (2013) Stevan Geoffrey Severtson et al. JOURNAL OF PAIN
- Attractiveness of reformulated OxyContin® tablets: assessing comparative preferences and tampering potential
- (2013) Edward M Sellers et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Assessment of Pharmacodynamic Effects Following Oral Administration of Crushed Morphine Sulfate and Naltrexone Hydrochloride Extended-Release Capsules Compared with Crushed Morphine Sulfate Controlled-Release Tablets and Placebo in Nondependent Recreational Opioid Users
- (2013) Beatrice Setnik et al. PAIN MEDICINE
- Changes in Prevalence of Prescription Opioid Abuse after Introduction of an Abuse-Deterrent Opioid Formulation
- (2013) Theresa A. Cassidy et al. PAIN MEDICINE
- Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxycodone with abuse-deterrent characteristics
- (2013) Paul M. Coplan et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Impact of Intravenous Naltrexone on Intravenous Morphine-Induced High, Drug Liking, and Euphoric Effects in Experienced, Nondependent Male Opioid Users
- (2013) Lynn R. Webster et al. Drugs in research & development
- Abuse Rates and Routes of Administration of Reformulated Extended-Release Oxycodone: Initial Findings From a Sentinel Surveillance Sample of Individuals Assessed for Substance Abuse Treatment
- (2012) Stephen F. Butler et al. JOURNAL OF PAIN
- Subjective Effects and Safety of Whole and Tampered Morphine Sulfate and Naltrexone Hydrochloride (ALO-01) Extended-Release Capsules versus Morphine Solution and Placebo in Experienced Non-Dependent Opioid Users
- (2009) Joseph Stauffer et al. CLINICAL DRUG INVESTIGATION
- Update on Abuse-Resistant and Abuse-Deterrent Approaches to Opioid Formulations
- (2009) Lynn Webster PAIN MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now